Hemnet Group AB – Unsponsored ADR (OTCMKTS:HMNTY – Get Free Report) was the target of a large decrease in short interest during the month of October. As of October 15th, there was short interest totaling 62 shares, a decrease of 98.3% from the September 30th total of 3,557 shares. Based on an average daily trading volume, of 121 shares, the short-interest ratio is presently 0.5 days. Approximately 0.0% of the shares of the company are short sold.
Hemnet Group Stock Performance
HMNTY traded down $0.34 during trading on Monday, hitting $7.46. The stock had a trading volume of 593 shares, compared to its average volume of 1,620. Hemnet Group has a 12 month low of $6.40 and a 12 month high of $24.68. The company has a 50 day simple moving average of $8.07 and a 200-day simple moving average of $9.46.
Analyst Ratings Changes
Separately, Nordea Equity Research upgraded shares of Hemnet Group to a “buy” rating in a research report on Tuesday, July 21st. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Reduce”.
About Hemnet Group
Hemnet Group AB operates Hemnet, Sweden’s leading online property marketplace. Through its platform, individuals can search for homes and other properties for sale, while real estate agents and property sellers can publish listings and market residential properties to prospective buyers.
The company’s services include property listings, search and comparison tools, saved searches, alerts and digital features designed to support the home-buying and selling process. Hemnet also offers advertising and visibility products for agents, developers and other property-related businesses.
Hemnet was established in Sweden in 1998 and primarily serves the Swedish residential real estate market through its Hemnet.se platform.
Recommended Stories
- Five stocks we like better than Hemnet Group
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Hemnet Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemnet Group and related companies with MarketBeat.com's FREE daily email newsletter.
